Rh Antibody Titre / Anti-D Titre Test

Rh Antibody Titre / Anti-D Titre Test

The Rh Antibody Titre (Anti-D Titre Test) measures the level of anti-D antibodies in the blood. These antibodies are produced when an Rh-negative (Rh−) person is exposed to Rh-positive (Rh+) red blood cells. This test is particularly important during pregnancy and blood transfusions to prevent hemolytic disease of the newborn (HDN) and transfusion reactions.


Why is the Test Done?

During Pregnancy (for Rh-negative mothers) – To check if the mother has developed anti-D antibodies against an Rh-positive baby’s blood.
Before Blood Transfusions – To ensure Rh compatibility between donor and recipient.
After Miscarriage, Abortion, or Ectopic Pregnancy – To detect Rh sensitization.
After Trauma During Pregnancy – If there is a risk of fetal-maternal bleeding (e.g., car accident).


How is the Test Done?

  1. Blood Sample Collection:

    • A blood sample is taken from a vein.
    • The test is performed using Indirect Coombs Test (ICT).
  2. Measuring the Antibody Levels:

    • Results are given as a titre (1:2, 1:4, 1:8, etc.), indicating the dilution at which antibodies are still detectable.

Interpreting the Results

Anti-D Titre Result Interpretation
Negative (Undetectable titre) No anti-D antibodies present (no Rh sensitization)
Low Titre (≤1:8) Minimal risk; monitoring continues
High Titre (>1:16 or >1:32) Increased risk of Hemolytic Disease of the Newborn (HDN)

📌 Note:

  • A negative result means no Rh sensitization has occurred.
  • A rising titre suggests Rh sensitization, which may cause HDN in the baby.
  • If titre is >1:16, fetal monitoring and further testing (e.g., Doppler ultrasound of the middle cerebral artery) are needed.

Next Steps Based on Results

🔬 Additional Tests May Be Ordered:

  • Indirect Coombs Test (ICT) – Confirms Rh sensitization.
  • Fetal Doppler Ultrasound – Checks for signs of fetal anemia.
  • Amniocentesis – Measures bilirubin levels in the amniotic fluid.

💊 Management & Treatment:

  • If Rh-negative mother is NOT sensitized:
    • Rh immunoglobulin (RhoGAM) injection at 28 weeks and within 72 hours after delivery if the baby is Rh-positive.
  • If Rh-negative mother is sensitized (Positive Anti-D Titre):
    • Close fetal monitoring for signs of hemolytic disease.
    • In severe cases, intrauterine blood transfusion may be needed.

Original price was: ₹800.00.Current price is: ₹449.00.

[whatsapp_booking]